{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:59:33Z","timestamp":1763726373286,"version":"3.45.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sociedad Mexicana de Nutrici\u00f3n y Endocrinolog\u00eda"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25070-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:47:47Z","timestamp":1763725667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proinflammatory markers in women with type 1 diabetes and polycystic ovary syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Manuel Ram\u00f3n","family":"Garc\u00eda-S\u00e1enz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitzia","family":"L\u00f3pez-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Valencia-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miry","family":"Lobaton-Ginsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Ramirez-Renteria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapy","family":"Leon-Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Sosa-Eroza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etual","family":"Espinosa-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Ferreira-Hermosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"4","key":"25070_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/humupd\/dmac011","volume":"28","author":"A Bayona","year":"2022","unstructured":"Bayona, A. et al. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: A systematic review and meta-analysis. Hum. Reprod. Update. 28 (4), 501\u2013517 (2022).","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"25070_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/dc15-2577","volume":"39","author":"HF Escobar-Morreale","year":"2016","unstructured":"Escobar-Morreale, H. F. & Roldan-Martin, M. B. Type 1 diabetes and polycystic ovary syndrome: Systematic review and Meta-analysis. Diabetes Care. 39 (4), 639\u2013648 (2016).","journal-title":"Diabetes Care"},{"issue":"1","key":"25070_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jc.2013-2669","volume":"99","author":"MC Amato","year":"2014","unstructured":"Amato, M. C. et al. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 99 (1), 203\u2013211 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"25070_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/cen.14281","volume":"93","author":"EP Thong","year":"2020","unstructured":"Thong, E. P., Milat, F., Joham, A. E., Mishra, G. D. & Teede, H. Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population-based study. Clin. Endocrinol. (Oxf). 93 (5), 564\u2013571 (2020).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"25070_CR5","doi-asserted-by":"publisher","first-page":"e1122","DOI":"10.1002\/cti2.1122","volume":"9","author":"J Lu","year":"2020","unstructured":"Lu, J., Liu, J., Li, L., Lan, Y. & Liang, Y. Cytokines in type 1 diabetes: Mechanisms of action and immunotherapeutic targets. Clin. Transl Immunol. 9 (3), e1122 (2020).","journal-title":"Clin. Transl Immunol."},{"issue":"5","key":"25070_CR6","first-page":"569","volume":"60","author":"MR Garcia-Saenz","year":"2022","unstructured":"Garcia-Saenz, M. R., Ferreira-Hermosillo, A. & Lobaton-Ginsberg, M. [Proinflammatory cytokines in polycystic ovarian syndrome]. Rev. Med. Inst. Mex Seguro Soc. 60 (5), 569\u2013576 (2022).","journal-title":"Rev. Med. Inst. Mex Seguro Soc."},{"issue":"3","key":"25070_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass, S., Divakar Prabhu, Y. & Valsala Gopalakrishnan, A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): An update. Arch. Gynecol. Obstet. 303 (3), 631\u2013643 (2021).","journal-title":"Arch. Gynecol. Obstet."},{"key":"25070_CR8","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S. et al. The role of chronic inflammation in polycystic ovarian Syndrome-A systematic review and Meta-Analysis. Int. J. Mol. Sci. ;22(5). (2021).","DOI":"10.3390\/ijms22052734"},{"key":"25070_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2017.01.002","volume":"94","author":"YL Chen","year":"2017","unstructured":"Chen, Y. L. et al. Correlation between serum interleukin-6 level and type 1 diabetes mellitus: A systematic review and meta-analysis. Cytokine 94, 14\u201320 (2017).","journal-title":"Cytokine"},{"issue":"3","key":"25070_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"HF Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale, H. F., Luque-Ramirez, M. & Gonzalez, F. Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis. Fertil. Steril. 95 (3), 1048\u201358e1 (2011).","journal-title":"Fertil. Steril."},{"issue":"10","key":"25070_CR11","doi-asserted-by":"publisher","first-page":"e0164021","DOI":"10.1371\/journal.pone.0164021","volume":"11","author":"L Gao","year":"2016","unstructured":"Gao, L., Gu, Y. & Yin, X. High serum tumor necrosis Factor-Alpha levels in women with polycystic ovary syndrome: A Meta-Analysis. PLoS One. 11 (10), e0164021 (2016).","journal-title":"PLoS One"},{"issue":"4","key":"25070_CR12","doi-asserted-by":"publisher","first-page":"e0176157","DOI":"10.1371\/journal.pone.0176157","volume":"12","author":"YC Qiao","year":"2017","unstructured":"Qiao, Y. C. et al. The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. PLoS One. 12 (4), e0176157 (2017).","journal-title":"PLoS One"},{"issue":"7","key":"25070_CR13","doi-asserted-by":"publisher","first-page":"102895","DOI":"10.1016\/j.arcmed.2023.102895","volume":"54","author":"MR Garcia-Saenz","year":"2023","unstructured":"Garcia-Saenz, M. R. et al. Hirsutism and polycystic ovarian morphology are the most frequent components of polycystic ovary syndrome in women with type 1 diabetes. Arch. Med. Res. 54 (7), 102895 (2023).","journal-title":"Arch. Med. Res."},{"issue":"1","key":"25070_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser, B. C. et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil. Steril. 97 (1), 28\u201338 (2012). e25.","journal-title":"Fertil. Steril."},{"issue":"2","key":"25070_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: The complete task force report. Fertil. Steril. 91 (2), 456\u2013488 (2009).","journal-title":"Fertil. Steril."},{"issue":"1","key":"25070_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","volume":"50","author":"S Chang","year":"2021","unstructured":"Chang, S. & Dunaif, A. Diagnosis of polycystic ovary syndrome: Which criteria to use and when? Endocrinol. Metab. Clin. North. Am. 50 (1), 11\u201323 (2021).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"25070_CR17","doi-asserted-by":"crossref","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. ;120(16):1640-5. (2009).","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"25070_CR18","first-page":"i","volume":"894","author":"Obesity","year":"2000","unstructured":"Obesity. Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, i\u2013xii (2000).","journal-title":"World Health Organ. Tech. Rep. Ser."},{"issue":"3","key":"25070_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson, T. A. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107 (3), 499\u2013511 (2003).","journal-title":"Circulation"},{"issue":"9","key":"25070_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/oby.2000.86","volume":"8","author":"L Roytblat","year":"2000","unstructured":"Roytblat, L. et al. Raised interleukin-6 levels in obese patients. Obes. Res. 8 (9), 673\u2013675 (2000).","journal-title":"Obes. Res."},{"issue":"7","key":"25070_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/oby.2001.54","volume":"9","author":"B Vozarova","year":"2001","unstructured":"Vozarova, B. et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9 (7), 414\u2013417 (2001).","journal-title":"Obes. Res."},{"key":"25070_CR22","unstructured":"Cohen, J. Statistical power analysis for the behavioral sciences. 2nd edition. Lawrence Erlbaum Associates. (1988)."},{"issue":"11","key":"25070_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","volume":"116","author":"KM Pou","year":"2007","unstructured":"Pou, K. M. et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation 116 (11), 1234\u20131241 (2007).","journal-title":"Circulation"},{"issue":"4","key":"25070_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1155\/2009\/465203","volume":"26","author":"N Samy","year":"2009","unstructured":"Samy, N., Hashim, M., Sayed, M. & Said, M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis. Markers. 26 (4), 163\u2013170 (2009).","journal-title":"Dis. Markers"},{"issue":"Suppl 2","key":"25070_CR25","first-page":"161","volume":"59","author":"K Zwirska-Korczala","year":"2008","unstructured":"Zwirska-Korczala, K. et al. Postprandial response of Ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. J. Physiol. Pharmacol. 59 (Suppl 2), 161\u2013178 (2008).","journal-title":"J. Physiol. Pharmacol."},{"issue":"7","key":"25070_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/01443615.2019.1581754","volume":"39","author":"M Kurek Eken","year":"2019","unstructured":"Kurek Eken, M. et al. Association between Circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. J. Obstet. Gynaecol. 39 (7), 975\u2013980 (2019).","journal-title":"J. Obstet. Gynaecol."},{"key":"25070_CR27","doi-asserted-by":"publisher","first-page":"389317","DOI":"10.1155\/2011\/389317","volume":"2011","author":"AM Fulghesu","year":"2011","unstructured":"Fulghesu, A. M. et al. IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm. 2011, 389317 (2011).","journal-title":"Mediators Inflamm."},{"issue":"6","key":"25070_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpag.2014.01.104","volume":"27","author":"M Pawelczak","year":"2014","unstructured":"Pawelczak, M., Rosenthal, J., Milla, S., Liu, Y. H. & Shah, B. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-alpha in adolescents with polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol. 27 (6), 356\u2013359 (2014).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"11","key":"25070_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","volume":"58","author":"K Eder","year":"2009","unstructured":"Eder, K., Baffy, N., Falus, A. & Fulop, A. K. The major inflammatory mediator interleukin-6 and obesity. Inflamm. Res. 58 (11), 727\u2013736 (2009).","journal-title":"Inflamm. Res."},{"key":"25070_CR30","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka, E. et al. Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci. 22, 3789 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"25070_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.numecd.2023.09.002","volume":"34","author":"Z Su","year":"2024","unstructured":"Su, Z., Efremov, L. & Mikolajczyk, R. Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: A systematic review and meta-analysis. Nutr. Metab. Cardiovasc. Dis. 34 (2), 251\u2013269 (2024).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"25070_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13679-025-00614-2","volume":"14","author":"M Diakosavvas","year":"2025","unstructured":"Diakosavvas, M., Oyebode, O. & Bhide, P. Weight management strategies to reduce metabolic morbidity in women with polycystic ovary syndrome. Curr. Obes. Rep. 14 (1), 22 (2025).","journal-title":"Curr. Obes. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25070-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25070-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25070-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:47:49Z","timestamp":1763725669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25070-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25070-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study. Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Local Ethics Committee (Comit\u00e9 Local de Investigaci\u00f3n y \u00c9tica en Investigaci\u00f3n en Salud) of the Hospital de Especialidades Centro M\u00e9dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. (R-2021-3601-129).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41308"}}